Open access
Open access
Powered by Google Translator Translator

Chest Medicine

Analysis: Managing Mental Health Challenges Faced by Healthcare Workers During Covid-19 Pandemic

27 Mar, 2020 | 03:55h | UTC

Managing mental health challenges faced by healthcare workers during covid-19 pandemic – The BMJ

Related Study: Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019 – JAMA Network Open AND Commentary: Survey Finds COVID-19 Takes Heavy Psychological Toll on Health Care Workers – Psychiatric News Alert

 


BCCDC Position Statement on Unproven Therapies for COVID-19

27 Mar, 2020 | 03:48h | UTC

Recommendation: Unproven Therapies for COVID-19 | March 24, 2020 – BC Centre for Disease Control

 


RSNA Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19

27 Mar, 2020 | 03:52h | UTC

Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. – Radiology

See also: COVID-19: Updates for Radiologists

 


Analysis: What is the Risk of Dying from COVID-19?

26 Mar, 2020 | 02:23h | UTC

What do we know about the risk of dying from COVID-19? – Our World in Data

Related: Global Covid-19 Case Fatality Rates – Centre for Evidence-Based Medicine, University of Oxford (free)

 


Postacute Care Preparedness for COVID-19: Thinking Ahead

26 Mar, 2020 | 01:52h | UTC

Postacute Care Preparedness for COVID-19: Thinking Ahead – JAMA

“Post-acute care preparedness for COVID19: we need to strengthen capacity in primary and community care to deal with those discharged from hospital.” (via @trishgreenhalgh see Tweet)

 


CEBM: Assessing Dyspnea by Telephone or Video

26 Mar, 2020 | 01:42h | UTC

Are there any evidence-based ways of assessing dyspnoea (breathlessness) by telephone or video – CEBM University of Oxford

 


Practical Advice: PPE Pearls

26 Mar, 2020 | 01:49h | UTC

Personal Protective Equipment (PPE) Pearls – COVID-19 – emDocs

 


Hydroxychloroquine: Small Study Shows No Benefit

26 Mar, 2020 | 01:39h | UTC

A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19) – Journal of Zhejiang University (abstract)

Commentary: Chloroquine Use For COVID-19 Shows No Benefit In First Small—But Limited—Controlled Trial – Forbes

Related: Coronavirus treatment hype can lead to harm – Lown Institute AND No, These Medicines Cannot Cure Coronavirus – The New York times

See also: Chloroquine for COVID-19: Cutting Through the Hype

 


New WHO Recommendations to Prevent Tuberculosis

25 Mar, 2020 | 02:55h | UTC

WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment – World Health Organization (free)

News Release: New WHO recommendations to prevent tuberculosis aim to save millions of lives – World Health Organization (free)

See also: Handbook (free)

Commentaries: Don’t forget chronic lung and immune conditions during covid-19, says WHO – The BMJ (free) AND As COVID-19 rages, WHO calls for more efforts to prevent TB – CIDRAP (free)

 


[Preprint] Incidence, Clinical Characteristics and Prognostic Factor of Patients with COVID-19: A Systematic Review and Meta-analysis

24 Mar, 2020 | 11:37h | UTC

Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis – medRxiv (free PDF)

Commentary: Study Calculates Just How Much Age, Medical Conditions Raise Odds Of Severe COVID-19 – NPR (free)

 


Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019

23 Mar, 2020 | 01:37h | UTC

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) – Intensive Care Medicine (free PDF)

Infographics: The Surviving Sepsis Campaign Rapid Guidelines on the Management of Critically Ill Adults with COVID-19 (free)

See also: COVID-19: Updates for Critical Care and Emergency Physicians (free resources)

 


NICE COVID-19 Rapid Guideline: Critical Care

23 Mar, 2020 | 01:32h | UTC

COVID-19 rapid guideline: critical care – National Institute for Health and Care Excellence (NICE)

See also: COVID-19: Updates for Critical Care and Emergency Physicians (free resources)

 


COVID-19: Updates for Critical Care and Emergency Physicians

25 May, 2020 | 00:01h | UTC

Guidelines:

Podcasts:

Videos:

Selected Articles:

“This pandemic has changed the risk-benefit balance for CPR: from “there is no harm in trying” to “there is little benefit to the patient, and potentially significant harm to staff.””

News & Perspectives:

COVID-19 Critical Care: This page will be updated as often as necessary and will be fixed in the right column on our homepage.

 


CEBM Estimates Infection Rate Fatality (IFR) of COVID-19 at 0,20%

23 Mar, 2020 | 01:16h | UTC

Global Covid-19 Case Fatality Rates – Centre for Evidence-Based Medicine, University of Oxford (free)

 


[Preprint] Randomized Trial: Favipiravir vs. Arbidol for COVID-19

23 Mar, 2020 | 01:18h | UTC

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial – medRxiv

 


Loss of Smell and Taste Could be a Sign of COVID-19

23 Mar, 2020 | 01:11h | UTC

Position Statement: Loss of sense of smell as marker of COVID-19 infection – ENT-UK

See also: There’s An Unexpected Loss Of Smell And Taste In Coronavirus Patients – Forbes  AND If you’ve lost your sense of smell or taste, you could be a ‘hidden carrier’ of the coronavirus – Business Insider

 


IDSA Statement: COVID-19 Prioritization of Diagnostic Testing

20 Mar, 2020 | 11:01h | UTC

COVID-19 Prioritization of Diagnostic Testing – Infectious Diseases Society of America (free PDF)

Summary: IDSA Statement On COVID-19 Testing Recommendations – Infectious Diseases Society of America (free)

 


Editorial by John P.A. Ioannidis: COVID-19: The Harms of Exaggerated Information and Non‐evidence‐based Measures

23 Mar, 2020 | 01:08h | UTC

Coronavirus disease 2019: the harms of exaggerated information and non‐evidence‐based measures – European Journal of Clinical Investigation (free PDF)

Related Opinion Piece: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data – STAT (free)

Rebuttal 1: We know enough now to act decisively against Covid-19. Social distancing is a good place to start – STAT (free)

Rebuttal 2: A Rebuttal to “A Fiasco in the Making?” – Hilda Bastian (Free)

 


New Preliminary Studies with Hydroxychloroquine:

20 Mar, 2020 | 10:57h | UTC

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial – International Journal of Antimicrobial Agents (free PDF)

This was an open-label study with only 42 patients without patient-relevant endpoints. The 6 patients that received Hydroxychloroquine + Azithromycin achieved more efficient virus elimination than control patients.

New in Vitro Study: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro – Cell Discovery (free)

Related Articles: In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – Clinical Infectious Diseases (free PDF) AND New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? – International Journal of Antimicrobial Agents (free) AND A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 – Journal of Critical Care (free) AND Of chloroquine and COVID-19 – Antiviral Research (free)

 


CDC Guideline: Strategies for Optimizing the Supply of Facemasks

20 Mar, 2020 | 11:03h | UTC

Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention (free)

 


Video: Coronavirus Update with Anthony Fauci, MD

19 Mar, 2020 | 11:04h | UTC

Coronavirus Update with Anthony Fauci, MD – March 18, 2020 – JAMA (free)

 


Podcast: New Research on Possible Treatments for Covid-19

19 Mar, 2020 | 10:57h | UTC

Interview with Dr. Eric Rubin and Dr. Lindsey Baden on new research on possible treatments for Covid-19 – New England Journal of Medicine (free)

 


State of the Art Review: Management of ANCA Associated Vasculitis

19 Mar, 2020 | 10:54h | UTC

Management of ANCA associated vasculitis – The BMJ (free)

 


Interim Guidance: Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection is Suspected

16 Mar, 2020 | 08:01h | UTC

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected – World Health Organization (free PDF)

Related: Severe SARS-CoV-2 Infections: Practical Considerations and Management Strategy for Intensivists (free studies and reviews)

 

Related Commentary on Twitter

 


Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response

16 Mar, 2020 | 07:55h | UTC

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response – JAMA (free)

Related Video: Coronavirus in Italy – Report From The Front Lines – JAMA (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.